Cost and Quality

Latest California Healthline Stories

KHN’s ‘What The Health?’: Waiting For The Trump Health Plan

President Donald Trump keeps promising a new health plan, but so far it’s nowhere to be seen. Meanwhile, Democratic presidential candidate Sen. Bernie Sanders (I-Vt.) is proposing a plan to cancel billions of dollars in medical debt owed by patients. This week, Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss these issues and more. Rovner also interviews KHN’s Rachel Bluth about the latest “Bill of the Month” feature. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.

Starving Seniors: How California’s Aging Are Falling Through The Cracks

One in 12 older Californians struggle to find enough food to eat while the federal program intended to help hasn’t kept pace with the graying population. That’s worse than the national average, with particularly high numbers in the San Jose and Riverside areas.

A Young Woman, A Wheelchair And The Fight To Take Her Place At Stanford

Throughout her young life, Sylvia Colt-Lacayo has been told her disability didn’t need to hold her back. She graduated near the top of her high school class. She was co-captain of the mock trial team. In April, she learned she had been admitted to Stanford University with a full scholarship. Now, the struggle to fund the caregivers she needs to leave home is proving her toughest battle yet.

In India’s Slums, ‘Painkillers Are Part Of The Daily Routine’

As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.

Beset By Lawsuits And Criticism In U.S., Opioid Makers Eye New Market In India

What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.